A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL-Reference-Cited by-同舟云学术

A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL

Published:2019-04 Issue:2 Volume:39 Page:278-284
ISSN:2096-5230
Container-title:Current Medical Science
language:en
Short-container-title:CURR MED SCI

Author:

Deng Ling,Li Xue-lan,Ye De-sheng,Blockeel Christophe,Zhou Xing-yu,Chen Shi-ling,Chen Xin

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry

Link

http://link.springer.com/content/pdf/10.1007/s11596-019-2031-5.pdf

Reference45 articles.

1. Kawwass JF, Kissin DM, Kulkarni AD, et al. Safety of assisted reproductive technology in the United States, 2000–2011. JAMA, 2015, 313(1):88–90

2. Steward RG, Lan L, Shah AA, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256, 381 in vitro fertilization cycles. Fertil Steril, 2014, 101(4):967–973

3. Brinsden PR, Wada I, Tan SL, et al. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol, 1995, 102(10):767–772

4. Pfeifer S BSDD. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril, 2016, 106(7):1634–1647

5. Abbara A, Clarke S, Islam R, et al. A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial. Hum Reprod, 2017, 32(9):1915–1924

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The GnRH antagonist protocol;Handbook of Current and Novel Protocols for the Treatment of Infertility;2024

2. Relation of graphical follicle models to the cumulative live birth rate in GnRH-antagonist stimulation treatment cycles;2022-08-31

3. Treatment of Ovarian Hyperstimulation Syndrome;Ovarian Stimulation;2022-04-30

4. Ovarian Hyperstimulation: Diagnosis, Prevention, and Management;Seminars in Reproductive Medicine;2021-10-13

5. Ovarian hyperresponse following the sole administration of GnRH agonist;Combinatorial Chemistry & High Throughput Screening;2021-03-02